The JUPITER trial allowed us to examine the association of the LILRB5 Asp247Gly variant in the presence and absence of statins, revealing that homozygosity of Asp247 is associated with increased odds of myalgia regardless of statin allocation. This evidence concerns the gene LILRB5 and Myalgia.